p38 mitogen-activated protein kinase-dependent chemokine production, leukocyte recruitment, and hepatocellular apoptosis in endotoxemic liver injury

Annals of Surgery

Volumn 242, Issue 6, 2005, Pages 830-839

  Klintman, Daniel ^a   Li, Xiang ^a   Santen, Stefan ^a   Schramm, Rene ^a   Jeppsson, Bengt ^a   Thorlacius, Henrik ^a   Eggermont, ^b   Senninger, ^b   Clavien, ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; ALPHA CHEMOKINE; CHEMOKINE; ENDOTOXIN; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CELL INFILTRATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; LIVER CELL; LIVER INJURY; LIVER SINUSOID; LIVER TOXICITY; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEPSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CHEMOKINES, CXC; ENDOTOXEMIA; LEUKOCYTE ROLLING; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 28244467218     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000189132.86878.f7     Document Type: Conference Paper

References (53)

1. Jaeschke H. Farhood A, Smith CW. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol. 1991;261;G1051-G1056.
2. Holman JM Jr, Saba TM. Hepatocyte injury during post-operative sepsis: activated nemrophils as potential mediators. J Leukoc Biol. 1988;43:193-203.
3. Klintman D, Schramm R, Menger MD, et al. Leukocyte recruitment in hepatic injury; selectin-mediated leukocyte rolling is a prerequisite for CD18-dependent firm adhesion. J Hepatol. 2002;36:53-59.
4. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 1991:67:1033-1036.
5. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
6. Hahne M, Jager U, Isenmann S, et al. Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes. J Cell Biol. 1993;121:655-664.
7. Klintman D, Li X, Thorlacius H. Important role of P-selectin in leukocyte recruitment, hepatocellular injury and apoptosis in endotoxemic mice. Clin Diagn Lab Immunol. 2004;11:56-62.
8. Li X, Klintman D, Weitz-Schmidt G, et al. Lymphocyte function antigen-1 mediates leukocyte adhesion and subsequent liver damage in endotoxemic mice. Br J Pharmacol. 2004;141:709-716.
9. Li X, Klintman D, Wang Y, et al. Critical role of CXC chemokines in the extravasation process of leukocytes in endotoxemia. J Leukoc Biol. 2004;75:443-452.
10. Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signaling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov. 2003;2:717-726.
11. Ma XL, Kumar S, Gao F, et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation. 1999;99:1685-1691.
12. Gao F, Yue TL, Shi DW, et al. p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation. Cardiovasc Res. 2002;53:414-422.
13. Bachelor M, Bowden GT. UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression. Semin Cancer Biol. 2004;14:131-138.
14. Demet T, Lei X, Tingcun Z, et al. Mitogen-activated protein kinases mediate heat shock-induced delayed protection in mouse heart. Am J Physiol. 2001;281:H523-H532.
15. Ropert C. Closel M, Chaves AC, et al. Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages. J Immunol. 2003;171:1456-1465.
16. Khan MA, Kang J, Steiner TS. Enteroaggregative Escherichia coli fiagellin-induced interleukin-8 secretion requires Toll-like receptor 5-dependent p38 MAP kinase activation. Immunology. 2004;112:651-660.
17. Lee JC, Laydon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372:739-746.
18. Underwood DC, Osborn RR, Kotzer CJ, et al. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther. 2000;293:281-288.
19. Badger AM, Griswold DE, Kapadia R, et al. Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum. 2000;43:175-183.
20. Behr TM, Nerurkar SS, Nelson AH, et al. Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction. Circulation. 2001;104:1292-1298.
21. Oguro T, Takahashi Y, Ashino T, et al. Involvement of tumor necrosis factor alpha, rather than interleukin-1alpha/beta or nitric oxides in the heme oxygenase-1 gene expression by lipopolysaccharide in the mouse liver. FEBS Lett. 2002;516:63-66.
22. Dahle MK, Overland G, Myhre AE, et al. The phosphatidylinositol 3-kinase/protein kinase B signaling pathway is activated by lipoteichoic acid and plays a role in Kupffer cell production of interleukin-6 (IL-6) and IL-10. Infect Immun. 2004;72:5704-5711.
23. Barone FC, Irving EA, Ray AM, et al. SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther. 2001;296:312-321.
24. Rauen U, Polzar B, Stephan H, et al. Cold-induced apoptosis in cultured hepatocytes and liver endothelial cells: mediation by reactive oxygen species. FASEB J. 1999;13:155-168.
25. Josephs MD, Bahjat FR, Fukuzuka K, et al. Lipopolysaccharide and D-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand. Am J Physiol. 2000;278:R1196-R1201.
26. Choudhury BK, Wild JS, Alam R, et al. In vivo role of p38 mitogenactivated protein kinase in mediating the anti-inflammatory effects of CpG oligodeoxynucleotide in murine asthma. J Immunol. 2002;169:5955-5961.
27. Stambe C, Atkins RC, Tesch GH, et al. Blockade of p38alpha MAPK ameliorates acute inflammatory renal injury in rat anti-GBM glomerulonephritis J Am Soc Nephrol. 2003;14:338-351.
28. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.
29. Hewett JA, Jean PA, Kunkel SL, et al. Relationship between tumor necrosis factor-α and neutrophils in endotoxin-induced liver injury. Am J Physiol. 1993;265:G1011-G1015.
30. Feng L, Xia Y, Yoshimura T, et al. Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J Clin Invest. 1995;95:1009-1017.
31. Schmal H, Shanley TP, Jones ML, et al. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol. 1996;156:1963-1972.
32. Diab A, Abdalla H, Li HL, et al. Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1α attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect Immun. 1999;67:2590-2601.
33. Zhang P, Xie M, Zagorski J, et al. Attenuation of hepatic sequestration by anti-CINC antibody in endotoxic rats. Shock. 1995;4:262-268.
34. Means TK, Pavlovich RP, Roca D, et al. Activation of TNF-alpha transcription utilizes distinct MAP kinase pathways in different macrophage populations. J Leukoc Biol. 2000;67:885-893.
35. Weber SM, Chen JM, Levitz SM, et al. Inhibition of mitogen-acrivated protein kinase signaling by chloroquine. J Immunol. 2002;168:5303-5309.
36. Swantek JL, Cobb MH, Geppert TD. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Mol Cell Biol. 1997;17:6274-6282.
37. Brook M, Sully G, Clark AR, et al. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. FEBS Lett. 2000:483:57-61.
38. Nagahira A, Nagahira K, Murafuji H, et al. Identification of a novel inhibitor of LPS-induced TNF-alpha production with antiproliferative activity in monocyte/macrophages. Biochem Biophys Res Commun. 2001;281:1030-1036.
39. Mahidhara R, Billiar TR. Apoptosis in sepsis. Crit Care Med. 2000;28:N105-N113.
40. Lawson JA, Fisher MA, Simmons CA, et al. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury. Hepatology. 1998;28:761-767.
41. Faouzi S, Burckhardt BE, Hanson JC, et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-κB-independent, caspase-3-dependent pathway. J Biol Chem. 2001;276:49077-49082.
42. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med. 2002;30(suppl):58-63.
43. Ayala A, Deol ZK, Lehman DL, et al. Polymicrobial sepsis but not low dose endotoxin infusion causes decreased splenocyte 1L-2/IFN-γ release while increasing IL-4/IL-10 production. J Surg Res. 1994;56:579-585.
44. Cohen PS, Schmidtmayerova H, Dennis J, et al. The critical role of p38 MAP kinase in T cell HIV-1 replication. Mol Med. 1997;3:339-346.
45. Song GY, Chung CS, Chaudry IH, et al. MAPK p38 antagonism as a novel method of inhibiting lymphoid immune suppression in polymicrobial sepsis. Am J Physiol. 2001;281:C662-C669.
46. Beutler B, Millsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science. 1985;229:869-871.
47. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature. 1987;330:662-664.
48. Nakane A. Minagawa T, Kato K. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun. 1988:56:2563-2569.
49. Echtenacher B, Urbaschek R, Weigl K, et al. Treatment of experimental sepsis-induced immunoparalysis with TNF. Immunobiology. 2003;208:381-389.
50. Berg DJ, Kühn K., Rajewsky K, et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest. 1995;96:2339-2347.
51. Howard M, Muchamuel T, Andrade S, et al. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med. 1993:177:1205-1208.
52. Song GY, Chung CS, Chaudry IH, et al. What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? Surgery. 1999;126:378-383.
53. Van der Poll TA, Marchant WA, Buurman L, et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol. 1995;155:5397-5401.